Gofen & Glossberg’s DexCom DXCM Stock Holding History

Gofen & Glossberg’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$679K	Hold	6,000	–	–	0.02%	293
2022 Q3	$483K	Hold	6,000	–	–	0.01%	322
2022 Q2	$447K	Sell	6,000 -32	-0.5%	-$2.92K	0.01%	339
2022 Q1	$771K	Hold	6,032	–	–	0.02%	269
2021 Q4	$810K	Buy	6,032 +32	+0.5%	+$4.6K	0.02%	268
2021 Q3	$820K	Hold	6,000	–	–	0.02%	263
2021 Q2	$641K	Hold	6,000	–	–	0.02%	296
2021 Q1	$539K	Hold	6,000	–	–	0.01%	317
2020 Q4	$555K	Hold	6,000	–	–	0.02%	302
2020 Q3	$618K	Hold	6,000	–	–	0.02%	266
2020 Q2	$608K	Hold	6,000	–	–	0.02%	256
2020 Q1	$404K	Hold	6,000	–	–	0.02%	290
2019 Q4	$328K	Buy	+6,000	New	+$285K	0.01%	357

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gofen & Glossberg's DXCM Position: Q4 2022 in Review

Gofen & Glossberg held its DexCom (DXCM) position steady in Q4 2022 at 6,000 shares worth $679K. The position accounts for 0.02% of the portfolio, ranked #293.

Gofen & Glossberg first reported a position in DXCM in Q4 2019 and has held it in 13 quarters since. The position peaked at $820K in Q3 2021. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2022.

Gofen & Glossberg held 6,000 shares of DexCom worth $679K as of Q4 2022.
Gofen & Glossberg left its DexCom share count unchanged in Q4 2022.
DexCom made up 0.02% of Gofen & Glossberg's portfolio in Q4 2022, its #293 holding.
Gofen & Glossberg first reported a position in DexCom in Q4 2019 and has held it in 13 quarters since.
Gofen & Glossberg's DexCom position peaked at $820K in Q3 2021.
921 funds tracked by Wall St. Rank held DexCom as of Q4 2022.

Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.